| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029865290 |
| P356 | DOI | 10.1186/1750-1326-5-49 |
| P953 | full work available at URL | http://www.molecularneurodegeneration.com/content/5//49 |
| https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/1750-1326-5-49 | ||
| http://www.molecularneurodegeneration.com/content/5//49/abstract | ||
| http://www.molecularneurodegeneration.com/content/pdf/1750-1326-5-49.pdf | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21067594/pdf/?tool=EBI | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21067594/?tool=EBI | ||
| https://europepmc.org/articles/PMC2992530 | ||
| https://europepmc.org/articles/PMC2992530?pdf=render | ||
| https://link.springer.com/content/pdf/10.1186/1750-1326-5-49.pdf | ||
| P3181 | OpenCitations bibliographic resource ID | 2880813 |
| P932 | PMC publication ID | 2992530 |
| P698 | PubMed publication ID | 21067594 |
| P5875 | ResearchGate publication ID | 47741850 |
| P50 | author | Stuart A. Lipton | Q1520410 |
| Eliezer Masliah | Q28324209 | ||
| P2093 | author name string | Xue Zhang | |
| Tao Ma | |||
| Huaxi Xu | |||
| Shiyong Diao | |||
| Janet Hsu | |||
| Francesca-Fang Liao | |||
| Young-Don Kwak | |||
| Yaomin Chen | |||
| P2860 | cites work | Post-translational regulation of PTEN. | Q37270440 |
| Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling. | Q37377515 | ||
| CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia | Q37449836 | ||
| Nitric oxide in cell survival: a janus molecule | Q37532468 | ||
| Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors | Q37693081 | ||
| Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex | Q39229072 | ||
| Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells | Q39741931 | ||
| PTEN is destabilized by phosphorylation on Thr366. | Q40143795 | ||
| S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway | Q40376784 | ||
| Redox regulation of PTEN by S-nitrosothiols | Q40406877 | ||
| Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. | Q42091923 | ||
| Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. | Q42526186 | ||
| The biotin switch method for the detection of S-nitrosylated proteins | Q43830334 | ||
| Role of protein kinase B in Alzheimer's neurofibrillary pathology | Q44354353 | ||
| Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules | Q46176212 | ||
| Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology | Q46386533 | ||
| PTEN levels in Alzheimer's disease medial temporal cortex | Q46765558 | ||
| Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation | Q46785508 | ||
| PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning | Q46801102 | ||
| Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease | Q47198022 | ||
| Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo | Q48722189 | ||
| Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor. | Q53564939 | ||
| Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes? | Q56049682 | ||
| Phosphorylation of the PTEN tail regulates protein stability and function | Q22254305 | ||
| Role of S-nitrosylation in apoptosis resistance and carcinogenesis | Q23909851 | ||
| NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN | Q24292919 | ||
| Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities | Q24303650 | ||
| The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 | ||
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| E3 ligase Nedd4 promotes axon branching by downregulating PTEN | Q24630190 | ||
| Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway | Q24644113 | ||
| Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association | Q27620298 | ||
| Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse | Q28297001 | ||
| Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1 | Q28392426 | ||
| Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems | Q28586004 | ||
| Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination | Q28591752 | ||
| Ischemic Postconditioning as a Novel Avenue to Protect against Brain Injury after Stroke | Q29394624 | ||
| A role for nuclear PTEN in neuronal differentiation. | Q29568319 | ||
| Reversible inactivation of the tumor suppressor PTEN by H2O2 | Q29615204 | ||
| Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? | Q29619535 | ||
| Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity | Q30448692 | ||
| Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment | Q33740552 | ||
| Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc | Q33744696 | ||
| PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury | Q33892209 | ||
| Protein S-nitrosylation in health and disease: a current perspective | Q35020178 | ||
| Redox regulation of PI 3-kinase signalling via inactivation of PTEN | Q36266420 | ||
| Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins | Q36343293 | ||
| Cerebral preconditioning and ischaemic tolerance | Q36484538 | ||
| GSK-3 is essential in the pathogenesis of Alzheimer's disease. | Q36568147 | ||
| PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? | Q36733630 | ||
| Phosphatase PTEN in neuronal injury and brain disorders | Q36980931 | ||
| Phosphorylation keeps PTEN phosphatase closed for business | Q37083611 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 49 | |
| P577 | publication date | 2010-11-10 | |
| P1433 | published in | Molecular Neurodegeneration | Q15817329 |
| P1476 | title | NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration | |
| P478 | volume | 5 |
| Q38110376 | Aberrant protein s-nitrosylation in neurodegenerative diseases |
| Q45345903 | Analysis of PTEN ubiquitylation and SUMOylation using molecular traps. |
| Q36093051 | Ca2+ Binding/Permeation via Calcium Channel, CaV1.1, Regulates the Intracellular Distribution of the Fatty Acid Transport Protein, CD36, and Fatty Acid Metabolism |
| Q58781601 | Computational Structural Biology of -nitrosylation of Cancer Targets |
| Q38758536 | Controlling PTEN (Phosphatase and Tensin Homolog) Stability: A DOMINANT ROLE FOR LYSINE 66. |
| Q36674615 | Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress |
| Q34686983 | Differential regulation of BACE1 expression by oxidative and nitrosative signals |
| Q33942934 | Distinction of thioredoxin transnitrosylation and denitrosylation target proteins by the ICAT quantitative approach. |
| Q46210613 | External cys/cySS redox state modification controls the intracellular redox state and neurodegeneration via Akt in aging and Alzheimer's disease mouse model neurons |
| Q26851901 | Gasotransmitters in Gametogenesis and Early Development: Holy Trinity for Assisted Reproductive Technology-A Review |
| Q24610496 | Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics) |
| Q49532909 | Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes |
| Q37384680 | Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis |
| Q38027944 | Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. |
| Q38102887 | Methods for detection and characterization of protein S-nitrosylation |
| Q36767908 | Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress |
| Q35787066 | Mitochondrial ubiquitin ligase MITOL blocks S-nitrosylated MAP1B-light chain 1-mediated mitochondrial dysfunction and neuronal cell death |
| Q92265566 | Modifying PTEN recruitment promotes neuron survival, regeneration, and functional recovery after CNS injury |
| Q89552362 | Modulation of AMPA Receptors by Nitric Oxide in Nerve Cells |
| Q28079319 | Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide |
| Q62675748 | Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop? |
| Q37652356 | NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells |
| Q33775384 | Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain. |
| Q50222232 | Nitric Oxide Upregulates Proteasomal Protein Degradation in Neurons. |
| Q34451436 | Nitric oxide and histone deacetylases modulate cocaine-induced mu-opioid receptor levels in PC12 cells |
| Q38706678 | Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system |
| Q23921938 | Nitrosothiol signaling in anoikis resistance and cancer metastasis |
| Q38191314 | Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation. |
| Q35064223 | On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN) |
| Q46402658 | PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation |
| Q64070918 | PTEN S-nitrosylation by NOS1 inhibits autophagy in NPC cells |
| Q36452913 | PTEN at a glance |
| Q28512531 | PTEN degradation after ischemic stroke: a double-edged sword |
| Q48066104 | PTEN recruitment controls synaptic and cognitive function in Alzheimer's models. |
| Q54977045 | Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer. |
| Q38199441 | Protein S-nitrosylation in preconditioning and postconditioning |
| Q35653222 | Protein S-nitrosylation: role for nitric oxide signaling in neuronal death |
| Q26852767 | Protein-thiol oxidation and cell death: regulatory role of glutaredoxins |
| Q37111504 | Redox pioneer: Professor Stuart A. Lipton |
| Q35763044 | Regulation by S-nitrosylation of protein post-translational modification |
| Q47691876 | Regulation of the tumor suppressor PTEN by natural anticancer compounds |
| Q89172382 | Role of Nitric Oxide and Hydrogen Sulfide in Ischemic Stroke and the Emergent Epigenetic Underpinnings |
| Q41463056 | Role of PTEN-Akt-CREB Signaling Pathway in Nervous System impairment of Rats with Chronic Arsenite Exposure |
| Q35492444 | S-nitrosylation in the regulation of gene transcription |
| Q39070800 | S-nitrosylation of ascorbate peroxidase is part of programmed cell death signaling in tobacco Bright Yellow-2 cells |
| Q36266253 | S-nitrosylation triggers ABI5 degradation to promote seed germination and seedling growth |
| Q36266295 | S-nitrosylation-dependent proteasomal degradation restrains Cdk5 activity to regulate hippocampal synaptic strength |
| Q35693498 | S-nitrosylation: a radical way to protect the heart |
| Q37204147 | S-nitrosylation: specificity, occupancy, and interaction with other post-translational modifications |
| Q36232644 | SNOs Differ: Methodological and Biological Implications |
| Q39328325 | SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane |
| Q38179749 | Signaling by S-nitrosylation in the heart |
| Q26823024 | Strategies for profiling native S-nitrosylation |
| Q27022790 | Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders |
| Q38397575 | Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases |
| Q37209584 | TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice. |
| Q60584712 | The Emerging Role of Protein S-Nitrosylation in Cancer Metastasis |
| Q38400601 | The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease |
| Q88955683 | The functions and regulation of the PTEN tumour suppressor: new modes and prospects |
| Q38222880 | The role of post-translational modifications in acute and chronic cardiovascular disease |
| Q90669787 | The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease |
| Q38809310 | To eat, or NOt to eat: S-nitrosylation signaling in autophagy. |
| Q34451736 | Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models |
| Q24613053 | Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration |
Search more.